Abound Wealth Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23K Sell
31
-52
-63% -$4.89K ﹤0.01% 733
2026
Q1
$9.82K Buy
83
+12
+17% +$1.48K ﹤0.01% 558
2025
Q4
$8.94K Sell
71
-6
-8% -$783 ﹤0.01% 525
2025
Q3
$11.3K Sell
77
-37
-32% -$5.59K ﹤0.01% 469
2025
Q2
$17.8K Buy
114
+64
+128% +$10.1K 0.01% 351
2025
Q1
$8.24K Sell
50
-50
-50% -$8.31K ﹤0.01% 431
2024
Q4
$16.2K Sell
100
-15
-13% -$2.68K 0.01% 316
2024
Q3
$22.5K Buy
115
+14
+14% +$2.58K 0.01% 268
2024
Q2
$17.6K Sell
101
-5
-5% -$832 0.01% 277
2024
Q1
$18K Buy
106
+3
+3% +$562 0.01% 270
2023
Q4
$20.3K Buy
103
+1
+1% +$177 0.01% 255
2023
Q3
$17.8K Sell
102
-2
-2% -$363 0.01% 233
2023
Q2
$17.9K Buy
104
+27
+35% +$4.67K 0.01% 229
2023
Q1
$12.8K Hold
77
0.01% 258
2022
Q4
$11.3K Buy
77
+31
+67% +$4.59K 0.01% 248
2022
Q3
$6.83K Buy
+46
New +$7.69K ﹤0.01% 327

Other funds holding ZTS

Abound Wealth Management's ZTS Position: Q2 2026 in Review

Abound Wealth Management reduced its Zoetis (ZTS) stake by 63% in Q2 2026, selling an estimated $4.89K and leaving 31 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Abound Wealth Management first reported a position in ZTS in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.5K in Q3 2024. 231 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Abound Wealth Management held 31 shares of Zoetis worth $2.23K as of Q2 2026.
  • Abound Wealth Management sold 52 Zoetis shares in Q2 2026, an estimated $4.89K.
  • Zoetis made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #733 holding.
  • Abound Wealth Management first reported a position in Zoetis in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Zoetis position peaked at $22.5K in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.